New therapies for acute myocardial infarction: current state of research and future promise
- PMID: 29947546
- DOI: 10.2217/fca-2017-0047
New therapies for acute myocardial infarction: current state of research and future promise
Abstract
Progress has been made into research on new therapies, mechanical and pharmacological approaches and repair/regenerative cellular therapy to treat irreversible cardiovascular pathologies, such as acute myocardial infarction. Research into cellular therapies is exploring the use of new cellular types. Although the therapeutic effects of cell therapy remain modest, results from clinical trials are encouraging. To expand this improvement, advances are being made that involve the paracrine function of stem cells, the use of growth factors, miRNA and new biomaterials. In the near future, these therapies should become part of routine clinical practice.
Keywords: acute coronary syndromes; acute myocardial infarction (AMI); clinical trial; myocardial regeneration; myocardial repair; stem cell therapy; therapy; tissue engineering.
Similar articles
-
Adult Stem Cell Therapy for Cardiac Repair in Patients After Acute Myocardial Infarction Leading to Ischemic Heart Failure: An Overview of Evidence from the Recent Clinical Trials.Curr Cardiol Rev. 2017;13(3):223-231. doi: 10.2174/1573403X13666170502103833. Curr Cardiol Rev. 2017. PMID: 28464769 Free PMC article. Review.
-
The future of cell therapy for acute myocardial infarction.Nat Clin Pract Cardiovasc Med. 2006 Mar;3 Suppl 1:S129-32. doi: 10.1038/ncpcardio0432. Nat Clin Pract Cardiovasc Med. 2006. PMID: 16501619
-
[Stem cell therapy for myocardial regeneration: mechanisms and current clinical applications].G Ital Cardiol (Rome). 2008 Apr;9(4):234-50. G Ital Cardiol (Rome). 2008. PMID: 18543793 Review. Italian.
-
Acute Myocardial Infarction, Cardioprotection, and Muse Cells.Adv Exp Med Biol. 2018;1103:153-166. doi: 10.1007/978-4-431-56847-6_8. Adv Exp Med Biol. 2018. PMID: 30484228 Review.
-
Stem cells and injectable hydrogels: Synergistic therapeutics in myocardial repair.Biotechnol Adv. 2016 Jul-Aug;34(4):362-379. doi: 10.1016/j.biotechadv.2016.03.003. Epub 2016 Mar 11. Biotechnol Adv. 2016. PMID: 26976812 Review.
Cited by
-
Effects of the hospital-community-family trinity cardiac rehabilitation on patients with acute myocardial infarction after percutaneous coronary intervention: A randomized trial.Int J Nurs Sci. 2025 Feb 15;12(2):161-168. doi: 10.1016/j.ijnss.2025.02.010. eCollection 2025 Mar. Int J Nurs Sci. 2025. PMID: 40241865 Free PMC article.
-
A four-compound remedy AGILe protected H9c2 cardiomyocytes against oxygen glucose deprivation via targeting the TNF-α/NF-κB pathway: Implications for the therapy of myocardial infarction.Front Pharmacol. 2023 Jan 13;14:1050970. doi: 10.3389/fphar.2023.1050970. eCollection 2023. Front Pharmacol. 2023. PMID: 36713834 Free PMC article.
-
Exploring the effects of an online learning platform in stage III cardiac rehabilitation for individuals with coronary heart disease: Randomized controlled study.Medicine (Baltimore). 2024 Sep 13;103(37):e39497. doi: 10.1097/MD.0000000000039497. Medicine (Baltimore). 2024. PMID: 39287309 Free PMC article. Clinical Trial.
-
Effects of multidisciplinary exercise management on patients after percutaneous coronary intervention: A randomized controlled study.Int J Nurs Sci. 2022 Jun 21;9(3):286-294. doi: 10.1016/j.ijnss.2022.06.012. eCollection 2022 Jul. Int J Nurs Sci. 2022. PMID: 35891912 Free PMC article.
-
Three-Dimensional Printing/Bioprinting and Cellular Therapies for Regenerative Medicine: Current Advances.J Funct Biomater. 2025 Jan 16;16(1):28. doi: 10.3390/jfb16010028. J Funct Biomater. 2025. PMID: 39852584 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical